Physician profile
Stephanie Bollenbach
NPI 1104203058
$3,734.90
in general payments reported to CMS, 2019-2025
10 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.94 · 2021: $401 · 2022: $566 · 2023: $1,022 · 2024: $539 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,455 · Food and Beverage: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,454.53 |
| Food and Beverage | $1,280.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,243.21 | 2021-2024 | Da Vinci Surgical System |
| Davol INC. | $1,168.09 | 2023-2025 | Phasix Mesh |
| Tela Bio, INC. | $428.98 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| W. L. Gore & Associates, INC. | $281.55 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $198.12 | 2024 | Exparel |
| Medical Device Business Services, INC. | $124.60 | 2021 | |
| Allergan, INC. | $99.64 | 2022 | |
| Medtronic, INC. | $82.72 | 2024 | Signia |
| Baxter Healthcare | $75.05 | 2024 | Perclot |
| Acell, INC. | $32.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Bollenbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.